6 Quotes by Paul LaViolette

We're going to run some new plays, and we think they're going to provide us some more momentum.

I don't think it's gimmicky. I think it's a tremendous statement of confidence in our program, ... In the world of interventional cardiology where patients are elderly, diseased, suffering, we don't really think of ourselves as providing gimmicks.

What we get is diversification for Boston Scientific and growth, and we get that through CRM. Clearly, CRM is the key asset here.

We see real flaws in the method. We're not dealing with a system that has a lot of precedent and has a lot of transparency.

We are very confident in our proposal. We think the (recall) issues are very manageable.

If you want me to comment on accelerating share decline, I guess I would have to say we don't see it,